Aster DM Healthcare Limited — PPTs, 03-06-2026: Investor Presentation

Aster DM Healthcare's India business reported strong FY26 performance with revenue up 12% to INR 4,643 Cr and Operating EBITDA up 17% to INR 947 Cr (20.4% margin). Kerala and Karnataka & Maharashtra remain key revenue regions, while a diversified specialty mix reduces reliance on any single area. Average Revenue Per Occupied Bed (ARPOB) was INR 51,800.

The big move is the merger with Quality Care India (QCIL), set to create one of India's top 3 hospital chains. This combined entity will boast 10,623 beds and a proforma FY26 revenue of INR 9,273 Cr, with Operating EBITDA of INR 2,013 Cr (21.7% margin). This strategic move aims for greater scale, enhanced metrics, and geographic diversification across 9 states and 28 cities. Management sees 10-15% EBITDA upside from synergies in revenue, procurement, and operations.

The share swap for the merger is complete, with full NCLT approval expected by Q1FY27. The company plans to add 4,445 beds, increasing total capacity to 15,068 beds in the coming years. Strategy also focuses on operational efficiency, cost control, and tech adoption.